This Florida sterile-compounding pharmacy location presents a strategic acquisition opportunity for qualified pharmaceutical professionals seeking to establish or expand operations in the specialized 503A compounding sector. The facility represents an asset purchase of a non-operational pharmacy location positioned within a medical building environment.

FACILITY SPECIFICATIONS:
The 1,400 square foot facility features a professionally designed 96 square foot cleanroom environment previously certified under USP-797 standards. Recent capital improvements include new HEPA filtration systems, sterile compounding hood, and updated equipment infrastructure. The cleanroom configuration demonstrates compliance-ready design for sterile pharmaceutical compounding operations.

LOCATION AND LEASE TERMS:
Strategically positioned within an established medical building, the location benefits from proximity to healthcare providers and medical professionals. Current lease terms provide 24 months of occupancy at $2,300 monthly rent. Expansion opportunities exist through available adjacent and corridor units, enabling scalable growth within the same medical complex.

REGULATORY STATUS:
The facility previously maintained USP-797 certification, indicating established infrastructure for sterile compounding operations. Current state pharmacy licensing will require renewal by the acquiring entity. The existing cleanroom and equipment foundation provides a compliance-ready platform for regulatory approval processes.

INVESTMENT STRUCTURE:
Offered as an asset purchase at $500,000, this opportunity provides immediate access to specialized pharmaceutical infrastructure without operational legacy issues. The acquisition includes physical assets, equipment, and facility improvements while allowing the purchaser to establish independent operational protocols, staffing, and customer relationships.

This turnkey sterile-compounding facility offers qualified pharmaceutical professionals the opportunity to enter or expand within the specialized 503A market segment with established infrastructure and strategic medical building positioning.